Exploring the Pharmacological Mechanism of Duhuo Jisheng Decoction in Treating Osteoporosis Based on Network Pharmacology

被引:22
|
作者
Xiong, Zhencheng [1 ,2 ]
Zheng, Can [3 ]
Chang, Yanan [4 ]
Liu, Kuankuan [4 ]
Shu, Li [4 ]
Zhang, Chi [1 ,3 ,4 ,5 ,6 ]
机构
[1] Peking Univ, Inst Med Technol, Hlth Sci Ctr, Beijing, Peoples R China
[2] Peking Univ Third Hosp, Beijing, Peoples R China
[3] Peking Univ, Biomed Engn Dept, Beijing, Peoples R China
[4] Peking Univ Int Hosp, Cent Lab, Beijing, Peoples R China
[5] Peking Univ Int Hosp, Dept Orthoped, Beijing, Peoples R China
[6] Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China
关键词
OSTEOGENIC DIFFERENTIATION; STEM-CELLS; DATABASE;
D O I
10.1155/2021/5510290
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective. The purpose of this work is to study the mechanism of action of Duhuo Jisheng Decoction (DHJSD) in the treatment of osteoporosis based on the methods of bioinformatics and network pharmacology. Methods. In this study, the active compounds of each medicinal ingredient of DHJSD and their corresponding targets were obtained from TCMSP database. Osteoporosis was treated as search query in GeneCards, MalaCards, DisGeNET, Therapeutic Target Database (TTD), Comparative Toxicogenomics Database (CTD), and OMIM databases to obtain disease-related genes. The overlapping targets of DHJSD and osteoporosis were identified, and then GO and KEGG enrichment analysis were performed. Cytoscape was employed to construct DHJSD-compounds-target genes-osteoporosis network and protein-protein interaction (PPI) network. CytoHubba was utilized to select the hub genes. The activities of binding of hub genes and key components were confirmed by molecular docking. Results. 174 active compounds and their 205 related potential targets were identified in DHJSD for the treatment of osteoporosis, including 10 hub genes (AKT1, ALB, IL6, MAPK3, VEGFA, JUN, CASP3, EGFR, MYC, and EGF). Pathway enrichment analysis of target proteins indicated that osteoclast differentiation, AGE-RAGE signaling pathway in diabetic complications, Wnt signaling pathway, MAPK signaling pathway, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, calcium signaling pathway, and TNF signaling pathway were the specifically major pathways regulated by DHJSD against osteoporosis. Further verification based on molecular docking results showed that the small molecule compounds (Quercetin, Kaempferol, Beta-sitosterol, Beta-carotene, and Formononetin) contained in DHJSD generally have excellent binding affinity to the macromolecular target proteins encoded by the top 10 genes. Conclusion. This study reveals the characteristics of multi-component, multi-target, and multi-pathway of DHJSD against osteoporosis and provides novel insights for verifying the mechanism of DHJSD in the treatment of osteoporosis.
引用
收藏
页数:21
相关论文
共 50 条
  • [41] Molecular mechanism of Shengyang Yiwei Decoction in treating chronic kidney disease based on network pharmacology
    Lan, Xinpeng
    Ao, Wu Liji
    Li, Ji
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (12): : 6878 - 6887
  • [42] Efficacy of Duhuo Jisheng Decoction for Treating Cold-Dampness Obstruction Syndrome-Type Knee Osteoarthritis: A Pooled Analysis
    Zhao, Jinlong
    Liang, Guihong
    Pan, Jianke
    Yang, Weiyi
    Zeng, Lingfeng
    Liu, Jun
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [43] Determining the mechanism of pulsatilla decoction for treating gastric cancer: a network pharmacology-based study
    Huang, Siqi
    Qu, Manying
    Chen, Xiaowu
    Yu, Shaochen
    Kong, Fanhua
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [44] Exploring the pharmacological mechanism of Yanghe Decoction on HER2-positive breast cancer by a network pharmacology approach
    Zeng, Luting
    Yang, Kailin
    JOURNAL OF ETHNOPHARMACOLOGY, 2017, 199 : 68 - 85
  • [45] An investigation of the mechanism of ZiyinDianji decoction in treating follicular dysplasia based on network pharmacology and molecular docking
    Feng, Xue
    Zhou, Huifang
    Lu, Wentian
    Liu, Xinyuan
    Wu, Yue
    Dai, Yaxin
    CELLULAR AND MOLECULAR BIOLOGY, 2023, 69 (13) : 120 - 127
  • [46] Mechanism analysis of Buyang Huanwu decoction in treating atherosclerosis based on network pharmacology and in vitro experiments
    Wang, Jing
    Li, Jiajun
    Hu, Min
    CHEMICAL BIOLOGY & DRUG DESIGN, 2024, 103 (01)
  • [47] Decoding the Mechanism of Huanglian Jiedu Decoction in Treating Pneumonia Based on Network Pharmacology and Molecular Docking
    Li, Xianhai
    Tang, Hua
    Tang, Qiang
    Chen, Wei
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [48] Discussion on the mechanism of Lingguizhugan Decoction in treating hypertension based on network pharmacology and molecular simulation technology
    Dong, Qi
    Huang, Yu-Jiao
    Tao, Zhi-Yu
    Huang, Han-Yue
    Luo, Lin-Hui
    Zhang, Ying-Qing
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023,
  • [49] Mechanism of Guishao Yigong decoction in treating colorectal cancer based on network pharmacology and experimental validation
    Fan, Yuwen
    Wang, Quyi
    Zhang, Yun
    Wang, Yu
    Li, Wenwen
    Jiang, Shu
    Duan, Ji-nao
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2024,
  • [50] Efficacy of Duhuo Jisheng Decoction for Treating Cold-Dampness Obstruction Syndrome-Type Knee Osteoarthritis: A Pooled Analysis
    Zhao, Jinlong
    Liang, Guihong
    Pan, Jianke
    Yang, Weiyi
    Zeng, Lingfeng
    Liu, Jun
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022